Mr. Milinazzo has 15 years of experience in interventional cardiology, and will replace Ofir Paz, who announced his plans to step down in September.
Formerly, Mr. Milinazzo was the president and CEO of Orthofix International, where he worked with spine devices and orthopedic stem cell therapy.
More Articles on Devices:
Soft Tissue Regeneration Receives Market Approval for Rotator Cuff Repair Device
Alphatec Spine Receives FDA Clearance for 2 Cervical, Fixation Devices
Zimmer Recall Labeled High Risk by FDA
